Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report
Tóm tắt
Từ khóa
Tài liệu tham khảo
Domino KB, Anderson EA, Polissar NL, Posner KL. Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999; 88: 1370–9.
Castle WM, Jukes AJ, Griffiths CJ, Roden SM, Greenstreet YLA. Safety of ondansetron. Eur J Anaesthesiol 1992; 9(Suppl 6): 63–6.
Tolan MM, Fuhrman TM, Tsueda K, Lippmann SB. Perioperative extrapyramidal reactions associated with ondansetron (Letter). Anesthesiology 1999; 90: 340–1.
Blaine EM. Acute severe depression following perioperative ondansetron. S Afr Med J 1997; 87: 1013–4.
Bosek V, Hu P, Robinson L. Acute myocardial ischemia after administration of ondansetron hydrochloride. Anesthesiology 2000; 92: 885–7.
Baguley WA, Hay WT, Mackie KP, Cheney FW, Cullen BF. Cardiac dysrrhythmias associated with the intravenous administration of ondansetron and metoclopramide. Anesth Analg 1997; 84: 1380–1.
Saxena PR, Villalon CM. 5-Hydroxytryptamine: a chameleon in the heart. Trends Pharmacol Sci 1991; 12: 223–7.
Saxena PR, Villalon CM. Cardiovascular effects of serotonin agonists and antagonists. J Cradiovasc Pharmacol 1990; 15(Suppl 7): S17-S34.
Boike SC, Llson B, Zariffa N, Jorkasky DK Cardiovascular effects of i.v. granisetron at two administration rates and of ondansetron in healthy adults. Am J Health-Syst Pharm 1997; 54: 1172–76.
Watanabe H, Hasegawa A, Shinozaki T, Arita S, Chigira M. Possible cardiac side effects of granisetron, an antiemetic agent in patients with bone and soft-tissue sarcomas receiving cytotoxic chemotherapy. Cancer Chemother Pharmacol 1995; 35: 278–82.